BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
· financialcontent
AI Briefing
- BridgeBio Pharma awards inducement grants to 33 new employees totaling 67,247 shares of common stock.
- The compensation committee approved the equity grants under Nasdaq Listing Rule 5635(c)(4).
- BridgeBio focuses on developing medicines for genetic conditions.
Advertisement